Tag: cell & gene therapy manufacturing services market overview.

  • Global Cell & Gene Therapy Manufacturing Services Market Forecast 2024-2033: Estimated Market Size And Growth Rate

    Global Cell & Gene Therapy Manufacturing Services Market Forecast 2024-2033: Estimated Market Size And Growth Rate

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How Much Growth is Expected for the Cell & Gene Therapy Manufacturing Services Market from 2024 to 2033?

    The market size for manufacturing services in cell and gene therapy has seen a swift expansion in the past few years. It is expected to increase from $7.25 billion in 2023 to $8.55 billion in 2024 with a compound annual growth rate (CAGR) of 17.8%. Factors such as amplified research and development investments, regulatory assistance and structures, a growing pipeline of cell & gene therapies, collaborations and partnerships within the industry, as well as a rising global demand for personalized medicine are contributing to the growth observed during the historical period.

    The market size of cell & gene therapy manufacturing services is anticipated to witness accelerated growth in the upcoming years, rising to $15.77 billion in 2028 with a compound annual growth rate (CAGR) of 16.6%. This forecasted growth can be credited to different factors such as market maturity and commercialization, worldwide expansion of biopharmaceutical manufacturing, rising trend of outsourcing by pharmaceutical firms, advancements in automation and robotics, and the development of new therapeutic modalities. The key trends to watch during the forecasted period are the growing demand for energy efficiency, cutting-edge materials, technologies, compact and modular designs, transportation electrification, and a constant focus on safety and reliability.

    Claim Your Free Sample of the Global Cell & Gene Therapy Manufacturing Services Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp

    What Factors Are Encouraging Growth in the cell & gene therapy manufacturing services Market?

    The escalating prevalence of cancer and various targeted illnesses is anticipated to drive the trajectory of the cell and gene therapy manufacturing services market in the future. Cancer is a critical condition that causes the cells in one’s body to multiply rapidly and unrestrained, leading to irregular growth. Cell and gene therapies are emerging as hopeful new approaches against the increasing prevalence of cancer, thereby stimulating the need for innovative and effective treatment choices. For example, the American Cancer Society, a nonprofit organization which advocates for cancer in the US, reported in January 2023 that the number of cancer instances escalated from 1,898,160 in 2021 to 1,958,310 in 2023, demonstrating a growth rate of 3.16%. Hence, the rising prevalence of cancer and other target diseases is pushing the expansion of the cell and gene therapy manufacturing services market forward.

    Which Segments Play a Vital Role in the Cell & Gene Therapy Manufacturing Services Market?

    1) By Type: Gene Therapy, Cell Therapy

    2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases

    3) By Application: Commercial Manufacturing, Clinical Manufacturing

    4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

    What Trends Are Driving Change in the Cell & Gene Therapy Manufacturing Services Market?

    The growth in technological innovations is a primary trend emerging in the cell and gene therapy manufacturing services industry. Key industrial players are embracing new technological trends to maintain their competitiveness. A case in point is Charles River Laboratories International Inc., a U.S.-based pharmaceutical firm proficient in various preclinical and clinical labs as well as gene and cell therapy amenities, which launched the navigation Vector Platform (navigation) in October 2022. This platform streamlines the way to GMP Adeno-Associated Virus (AAV) vector production without the need for extensive process development. It can shorten a program’s timeline to GMP by 55% for viral vector gene therapy investigators in comparison to conventional manufacturing processes. The distinct approach of Charles River’s navigation relies on a high-yield HEK293 suspension cell line that can be expanded and serotyped to fulfil client requirements.

    Order Now for Fast Delivery of Your Cell & Gene Therapy Manufacturing Services Market Report!

    https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-global-market-report

    What Regions Are Contributing Significantly to the Growth of the Cell & Gene Therapy Manufacturing Services Market?

    North America was the largest region in the cell and gene therapy manufacturing services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Cell & Gene Therapy Manufacturing Services Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the cell & gene therapy manufacturing services market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Cell & Gene Therapy Manufacturing Services Market Include

    1. Cell & Gene Therapy Manufacturing Services Market Executive Summary

    2. Cell & Gene Therapy Manufacturing Services Market Segments

    3. Cell & Gene Therapy Manufacturing Services Market Size And Template Market Growth Rate

    4. Key Cell & Gene Therapy Manufacturing Services Market Trends

    5. Major Cell & Gene Therapy Manufacturing Services Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Cell & Gene Therapy Manufacturing Services Market

    26. Top Cell & Gene Therapy Manufacturing Services Companies

    27. Cell & Gene Therapy Manufacturing Services Market Opportunities And Strategies

    28. Cell & Gene Therapy Manufacturing Services Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    COVID-19 Detection Test Kits and Consumables Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/covid-19-detection-test-kits-and-consumables-global-market-report

    COVID-19 Rapid Test Kits Global Market Opportunities And Strategies To 2031

    https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market

    Power Generators Global Market Report 2023

    https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Future Growth Forecast For The Cell & Gene Therapy Manufacturing Services Global Market 2024-2033

    Future Growth Forecast For The Cell & Gene Therapy Manufacturing Services Global Market 2024-2033

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Market Expansion: An Overview

    • The cell & gene therapy manufacturing services market has witnessed rapid growth.
    • From $7.25 billion in 2023, it’s projected to reach $8.55 billion in 2024, boasting a CAGR of 17.8%.
    • The forecast anticipates further expansion, hitting $15.77 billion by 2028, with a CAGR of 16.6%.

    Driving Forces Behind Market Surge

    • Increased R&D Investments: Research and development initiatives fuel market growth.
    • Regulatory Support: Supportive frameworks foster innovation and commercialization.
    • Growing Pipeline of Therapies: A burgeoning pipeline of therapies drives demand for manufacturing services.
    • Industry Collaborations: Collaborations and partnerships drive efficiency and innovation.
    • Global Demand for Personalized Medicine: Rising demand for personalized treatments propels market growth.

    Rising Prevalence Of Cancer And Other Target Diseases To Drive Market Growth

    • Combatting Cancer Incidence: Cell and gene therapies offer promising solutions for combating cancer.
    • Incidence Statistics: The incidence of cancer continues to rise globally, demanding innovative treatment options.
    • Market Response: Companies focus on developing novel and efficient treatment choices to address rising disease burdens.
    • Key Market Players: Thermo Fisher Scientific Inc., Merck KGaA, and others lead the charge in providing advanced manufacturing services.

    View More On The Cell & Gene Therapy Manufacturing Services Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-global-market-report

    Technological Advancements Driving Innovation In Cell And Gene Therapy Manufacturing Services Market

    • Innovative Platforms: Companies develop platforms simplifying GMP manufacturing processes.
    • Charles River’s Navigation Platform: Charles River Laboratories introduces the navigation Vector Platform, revolutionizing viral vector gene therapy manufacturing.
    • Thermo Fisher’s Acquisition: Thermo Fisher expands its global presence in cell and gene therapy through the acquisition of Henogen SA.

    Exploring Market Segmentation and Regional Dynamics

    • Market Segmentation: The market is segmented by type, indication, application, and end-user.
    • Type Variation: Gene therapy and cell therapy represent significant segments.
    • Indication Spectrum: Therapies target various diseases including cancer, cardiovascular disorders, and infectious diseases.
    • Regional Influence: North America leads the market, while Asia-Pacific emerges as the fastest-growing region.

    Future Trends Reshaping the Landscape

    • Focus on Energy Efficiency: Companies prioritize energy-efficient manufacturing solutions.
    • Advanced Materials and Technologies: Innovations in materials and technologies drive manufacturing efficiency.
    • Compact and Modular Designs: Modular designs enable flexibility and scalability in manufacturing processes.
    • Electrification of Transportation: Adoption of electrified transportation solutions enhances sustainability.
    • Safety and Reliability: Emphasis on safety and reliability underscores market evolution.

    Embracing the Potential of Cell & Gene Therapy Manufacturing

    As the cell & gene therapy manufacturing services market evolves, stakeholders must navigate through dynamic trends and regulatory landscapes. With a relentless focus on innovation, collaboration, and patient-centric solutions, the market stands poised for unprecedented growth and transformation. From personalized medicine to disease eradication, the impact of cell and gene therapies reverberates across healthcare, shaping the future of medical interventions and patient outcomes.

    In conclusion, the journey of cell & gene therapy manufacturing services unfolds with promise and potential, driven by technological advancements and market dynamics. As pioneers in biopharmaceutical manufacturing pave the way for groundbreaking discoveries, the world awaits the transformative power of cell and gene therapies, poised to address the most pressing healthcare challenges with ingenuity and resilience.

    Request A Sample Of The Global Cell & Gene Therapy Manufacturing Services Market Report 2024:

    https://www.thebusinessresearchcompany.com/sample_request?id=10035&type=smp